360 related articles for article (PubMed ID: 34757450)
21. Clinical Features and Computed Tomography Radiomics-Based Model for Predicting Pancreatic Ductal Adenocarcinoma and Focal Mass-Forming Pancreatitis.
Ye Y; Zhang J; Song P; Qin P; Hu Y; An P; Li X; Lin Y; Wang J; Feng G
Technol Cancer Res Treat; 2023; 22():15330338231180792. PubMed ID: 37287274
[No Abstract] [Full Text] [Related]
22. Predicting the recurrence risk of renal cell carcinoma after nephrectomy: potential role of CT-radiomics for adjuvant treatment decisions.
Deniffel D; McAlpine K; Harder FN; Jain R; Lawson KA; Healy GM; Hui S; Zhang X; Salinas-Miranda E; van der Kwast T; Finelli A; Haider MA
Eur Radiol; 2023 Aug; 33(8):5840-5850. PubMed ID: 37074425
[TBL] [Abstract][Full Text] [Related]
23. Computerized tomography scan in pre-diagnostic pancreatic ductal adenocarcinoma: Stages of progression and potential benefits of early intervention: A retrospective study.
Singh DP; Sheedy S; Goenka AH; Wells M; Lee NJ; Barlow J; Sharma A; Kandlakunta H; Chandra S; Garg SK; Majumder S; Levy MJ; Takahashi N; Chari ST
Pancreatology; 2020 Oct; 20(7):1495-1501. PubMed ID: 32950386
[TBL] [Abstract][Full Text] [Related]
24. Current state of radiomic research in pancreatic cancer: focusing on study design and reproducibility of findings.
Malcolm JA; Tacey M; Gibbs P; Lee B; Ko HS
Eur Radiol; 2023 Oct; 33(10):6659-6669. PubMed ID: 37079029
[TBL] [Abstract][Full Text] [Related]
25. Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy.
Polk SL; Choi JW; McGettigan MJ; Rose T; Ahmed A; Kim J; Jiang K; Balagurunathan Y; Qi J; Farah PT; Rathi A; Permuth JB; Jeong D
World J Gastroenterol; 2020 Jun; 26(24):3458-3471. PubMed ID: 32655269
[TBL] [Abstract][Full Text] [Related]
26. Derivation and validation of a preoperative prognostic model for resectable pancreatic ductal adenocarcinoma.
Xu S; Zhang XP; Zhao GD; Zou WB; Zhao ZM; Liu Q; Hu MG; Liu R
Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):160-168. PubMed ID: 36171167
[TBL] [Abstract][Full Text] [Related]
27. Differentiation of atypical non-functional pancreatic neuroendocrine tumor and pancreatic ductal adenocarcinoma using CT based radiomics.
He M; Liu Z; Lin Y; Wan J; Li J; Xu K; Wang Y; Jin Z; Tian J; Xue H
Eur J Radiol; 2019 Aug; 117():102-111. PubMed ID: 31307634
[TBL] [Abstract][Full Text] [Related]
28. CT Radiomics-Based Preoperative Survival Prediction in Patients With Pancreatic Ductal Adenocarcinoma.
Park S; Sham JG; Kawamoto S; Blair AB; Rozich N; Fouladi DF; Shayesteh S; Hruban RH; He J; Wolfgang CL; Yuille AL; Fishman EK; Chu LC
AJR Am J Roentgenol; 2021 Nov; 217(5):1104-1112. PubMed ID: 34467768
[No Abstract] [Full Text] [Related]
29. Fully automated magnetic resonance imaging-based radiomics analysis for differentiating pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma.
Li Q; Zhou Z; Chen Y; Yu J; Zhang H; Meng Y; Zhu M; Li N; Zhou J; Liu F; Fang X; Li J; Wang T; Lu J; Zhang T; Xu J; Shao C; Bian Y
Abdom Radiol (NY); 2023 Jun; 48(6):2074-2084. PubMed ID: 36964775
[TBL] [Abstract][Full Text] [Related]
30. CT radiomics signature: a potential biomarker for fibroblast activation protein expression in patients with pancreatic ductal adenocarcinoma.
Meng Y; Yu J; Zhu M; Zhou J; Li N; Liu F; Zhang H; Fang X; Li J; Feng X; Wang L; Jiang H; Lu J; Shao C; Bian Y
Abdom Radiol (NY); 2022 Aug; 47(8):2822-2834. PubMed ID: 35451626
[TBL] [Abstract][Full Text] [Related]
31. A CT Radiomics-Based Risk Score for Preoperative Estimation of Intraoperative Superior Mesenteric-Portal Vein Involvement in Pancreatic Ductal Adenocarcinoma.
Zhou Y; Wang J; Zhang SL; Wang H; Yan Y; Qi X; Chen S; Chen FM
Ann Surg Oncol; 2023 Feb; 30(2):1206-1216. PubMed ID: 36264518
[TBL] [Abstract][Full Text] [Related]
32. Applying a radiomics-based strategy to preoperatively predict lymph node metastasis in the resectable pancreatic ductal adenocarcinoma.
Liu P; Gu Q; Hu X; Tan X; Liu J; Xie A; Huang F
J Xray Sci Technol; 2020; 28(6):1113-1121. PubMed ID: 33074215
[TBL] [Abstract][Full Text] [Related]
33. Development of a Novel Multiparametric MRI Radiomic Nomogram for Preoperative Evaluation of Early Recurrence in Resectable Pancreatic Cancer.
Tang TY; Li X; Zhang Q; Guo CX; Zhang XZ; Lao MY; Shen YN; Xiao WB; Ying SH; Sun K; Yu RS; Gao SL; Que RS; Chen W; Huang DB; Pang PP; Bai XL; Liang TB
J Magn Reson Imaging; 2020 Jul; 52(1):231-245. PubMed ID: 31867839
[TBL] [Abstract][Full Text] [Related]
34. Development and validation of a deep learning radiomics model with clinical-radiological characteristics for the identification of occult peritoneal metastases in patients with pancreatic ductal adenocarcinoma.
Shi S; Lin C; Zhou J; Wei L; Chen M; Zhang J; Cao K; Fan Y; Huang B; Luo Y; Feng ST
Int J Surg; 2024 May; 110(5):2669-2678. PubMed ID: 38445459
[TBL] [Abstract][Full Text] [Related]
35. Estimating Recurrence after Upfront Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinoma by Using Pancreatic CT: Development and Validation of a Risk Score.
Kim DW; Lee SS; Kim SO; Kim JH; Kim HJ; Byun JH; Yoo C; Kim KP; Song KB; Kim SC
Radiology; 2020 Sep; 296(3):541-551. PubMed ID: 32662759
[TBL] [Abstract][Full Text] [Related]
36. A predictive model for recurrence after upfront surgery in patients with resectable pancreatic ductal adenocarcinoma (PDAC) by using preoperative clinical data and CT characteristics.
Tian N; Wu D; Zhu L; Zeng M; Li J; Wang X
BMC Med Imaging; 2022 Jul; 22(1):116. PubMed ID: 35786426
[TBL] [Abstract][Full Text] [Related]
37. Preoperative Radiomics Approach to Evaluating Tumor-Infiltrating CD8
Bian Y; Liu C; Li Q; Meng Y; Liu F; Zhang H; Fang X; Li J; Yu J; Feng X; Ma C; Zhao Z; Wang L; Xu J; Shao C; Lu J
J Magn Reson Imaging; 2022 Mar; 55(3):803-814. PubMed ID: 34355834
[TBL] [Abstract][Full Text] [Related]
38. Two nomograms for differentiating mass-forming chronic pancreatitis from pancreatic ductal adenocarcinoma in patients with chronic pancreatitis.
Zhang H; Meng Y; Li Q; Yu J; Liu F; Fang X; Li J; Feng X; Zhou J; Zhu M; Li N; Lu J; Shao C; Bian Y
Eur Radiol; 2022 Sep; 32(9):6336-6347. PubMed ID: 35394185
[TBL] [Abstract][Full Text] [Related]
39. Prognostic stratification in patients with pancreatic ductal adenocarcinoma after curative resection based on preoperative pancreatic contrast-enhanced CT findings.
Li D; Wang L; Cai W; Liang M; Ma X; Zhao X
Eur J Radiol; 2022 Jun; 151():110313. PubMed ID: 35447500
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic cancer, radiomics and artificial intelligence.
Marti-Bonmati L; Cerdá-Alberich L; Pérez-Girbés A; Díaz Beveridge R; Montalvá Orón E; Pérez Rojas J; Alberich-Bayarri A
Br J Radiol; 2022 Sep; 95(1137):20220072. PubMed ID: 35687700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
